Esco Aster spinoff transactions
We are advising Esco Lifesciences on the spinoff
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Oak Street Health $180.3 million secondary offering
We advised the joint book-running managers on the equity offering
Tenaya Therapeutics $75 million at-the-market offering
The common stock is listed on the Nasdaq Global Select Market
Banco Santander $3.5 billion senior non-preferred notes offering
We advised Banco Santander on its offering of fixed-rate notes
LIV Capital Acquisition Corp. II $547 million combination with Covalto
We are advising LIV Capital Acquisition Corp. II, a SPAC, on the transaction
Total victory for Uniti Group in securities fraud action
We secured a total victory for Uniti when the Third Circuit affirmed the dismissal of common law fraud and securities claims
ADC Therapeutics $175 million term loan facility and other financings
We advised the company on the new facility, a $115 million exchange and a $6.25 million share sale
Crestview Partners strategic investment in Digicomm International
We advised Crestview Partners on the transaction
Murphy Oil $200 million tender offers
We advised Murphy Oil on its tender offers for two tranches of notes
Texas Instruments $700 million notes offering
We advised Texas Instruments on its investment-grade debt offering